首页> 外文期刊>The Journal of Urology >Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
【24h】

Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.

机译:前列腺癌放疗后雄激素剥夺治疗对柠檬酸西地那非反应的影响分析。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: Radiation therapy is a widely accepted strategy for prostate cancer. Erectile dysfunction is a common complication of radiation therapy. Adjuvant androgen deprivation was shown to prolong survival in select patients. There is controversy regarding the impact of androgen deprivation on erectile function. We defined the impact of androgen deprivation on the sildenafil response in patients with erectile dysfunction following radiation therapy. MATERIALS AND METHODS: Patients were enrolled prospectively if they underwent radiation therapy in the form of 3-dimensional conformal external beam or brachytherapy with or without androgen deprivation, reported functional erections before radiation therapy, experienced the onset of erectile dysfunction following the completion of radiation therapy, had comprehensive erectile dysfunction evaluation, including a thorough history and physical examination, attempted sildenafil periodically and completed the International Index of Erectile Function on at least2 occasions throughout the first 3 years following the completion of radiation therapy. RESULTS: A total of 152 patients were enrolled. Mean age +/- SD was 62 +/- 14 years. No significant difference existed in age or radiation dose between patients with and without androgen deprivation exposure. Mean androgen deprivation duration was 3.8 +/- 1.8 months. For patients with conformal external beam and brachytherapy the sildenafil response, mean erectile function domain score and percent who experienced erectile function domain normalization at each time point were lower in those with vs without androgen deprivation. CONCLUSIONS: Androgen deprivation seems to exert a deleterious effect on erectile function in men undergoing radiation therapy for prostate cancer. This was observed in men treated with conformal external beam and brachytherapy at short-term, medium term and long-term followup.
机译:目的:放射治疗是前列腺癌广泛接受的策略。勃起功能障碍是放射治疗的常见并发症。佐剂性雄激素剥夺可延长部分患者的生存期。关于雄激素剥夺对勃起功能的影响存在争议。我们定义了雄激素剥夺对放射治疗后勃起功能障碍患者西地那非反应的影响。材料和方法:如果患者接受3D保形外束或近距离放射疗法(伴有或不伴有雄激素剥夺),放疗前报告功能性勃起,放疗完成后出现勃起功能障碍,则接受前瞻性入组。进行了全面的勃起功能障碍评估,包括彻底的病史和体格检查,定期尝试西地那非,并在放疗结束后的头三年内至少两次完成国际勃起功能指数的评估。结果:共纳入152例患者。平均年龄+/- SD为62 +/- 14岁。有和没有雄激素剥夺暴露的患者之间的年龄或放射剂量没有显着差异。平均雄激素剥夺持续时间为3.8 +/- 1.8个月。对于具有保形外束和近距离放射治疗的患者,sildenafil反应,平均勃起功能域评分和在每个时间点经历勃起功能域正常化的百分比在有无雄激素剥夺的患者中均较低。结论:雄激素剥夺似乎对接受前列腺癌放射治疗的男性的勃起功能产生有害影响。在短期,中期和长期随访中,在接受保形外束和近距离放射治疗的男性中观察到了这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号